Vicarious Surgical (RBOT) Notes Payables (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Notes Payables of $525000.0 for Q4 2025, up 323.39% quarter-over-quarter from $124000.0 in Q2 2020.
Vicarious Surgical (RBOT) Notes Payables (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Notes Payables for 2 consecutive years, with $525000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Notes Payables changed N/A year-over-year to $525000.0; the TTM figure through Dec 2025 stood at $525000.0 (changed N/A YoY), while the FY2025 annual figure was $525000.0, changed N/A from the prior year.
- Notes Payables advanced to $525000.0 in Q4 2025 per RBOT's latest filing, from $124000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $525000.0 in Q4 2025 and bottomed at $525000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 525,000.00 |
| Jun 30, 2020 | 124,000.00 |